GRS Newsletter – December 2020
What a turbulent year this has been. COVID-19 has forced change and devastation on people all around the world and we continue to monitor this daily. We are fortunate and grateful to be in [...]
Psoriatic Arthritis – Symptoms, Treatment & Clinical Trials
Psoriatic arthritis (PsA) is a type of inflammatory arthritis in which the immune system starts to target the body’s own joints. It is most commonly associated with psoriasis, which is a chronic autoimmune skin condition [...]
Good Clinical Practice (ICH GCP) Course Updates
Thank you to all who have completed our free online ICH-GCP training course and provided feedback. We appreciate you taking the time to answer our student evaluation survey. We have reviewed your survey [...]
Clinical Trial Feasibility and Capacity Planning Tool
1. GENERAL INFORMATION Full Study Title and Trial Number: Sponsor: PI Undertaking Study: Intended Study Commencement Date: HREC Submission Date: Date of Site Selection: Assigned Lead CTC: Start Up Primary Contact Sponsor/CRO: Name: Email: [...]
Medical Writing – What Does a Medical Writer Do?
Medical writing is a profession dedicated to the communication of medical, scientific and health information, including research reports, consumer (patient) information, and regulatory documents. What is a Medical Writer? A professional medical writer is [...]
GRS Newsletter – February 2020
Welcome to the new year with Genesis. First of all, our thoughts go out to those affected by the bushfires here in Australia. Our deepest gratitude goes out to the incredible people fighting the [...]
Investigators Meeting – Kuala Lumpur, December 2019 – Rheumatoid Arthritis Study
Our clinical trial coordinators, Ashlie and Katie, were very fortunate to attend an investigators meeting with GlaxoSmithKline (GSK) at the Kuala Lumpur Convention Centre in December 2019. During the two-day conference, Ashlie and Katie learnt [...]
Investigators Meeting – San Diego, November 2019 – Osteoarthritis of the Knee Study
Last month, our clinical trial coordinator, Michael, and investigator, Dr Uli Liedvogel, jetted off to San Diego, California, USA, to attend an investigators meeting for a new osteoarthritis of the knee study that will [...]
Participant Recruitment – celebrating 5 years on social media
5 years ago... 5 years ago we decided to join our first social media platform, Facebook and use it as a means to connect local people with clinical trials. We were frustrated by the available [...]
Medical Devices – Intrathecal Drug Pump Therapy for Chronic Pain
Drug pump therapy is an advanced treatment option for chronic pain patients who haven’t achieved enough pain relief with other treatments. Drug pump therapy is known by many other names, such as pain pump therapy, [...]
GRS Newsletter – September 2019
This year has been exceptionally busy for Genesis! We waved goodbye to our longest serving team member and welcomed new staff and investigators. We celebrated significant study enrolment milestones and the initiation of our [...]
Degenerative Disc Disease – Symptoms, Treatment & Clinical Trials
Spinal discs naturally degenerate with age due to wear-and-tear, but this doesn’t always lead to pain or other symptoms. Degenerative disc disease (DDD) is a condition (not actually a disease) in which degenerated discs [...]
Did You Know that Genesis Conducts its Own Studies?
Most clinical trials are developed, funded and managed by pharmaceutical or medical device companies. Here at Genesis Research, we also conduct “investigator-initiated studies”. These are research studies that are developed and managed by our own [...]
Genesis Workplace Health and Safety
Over the past 4 years GRS has created and implemented a unique and standardised framework for workplace health and safety in clinical trials research at a site level. This robust system represents our strong [...]
Migraine – Symptoms, Treatment & Clinical Trials
Migraine is a neurological disorder that is typically defined as recurring attacks of moderate to severe headaches and accompanying symptoms (particularly neurological and sensory symptoms). Migraine may be a primary condition, or it may [...]
A Business Case for a Pain-Neuromodulation Research Network
Clinical trial sites in Australia provide valuable and meaningful contribution to their local and surrounding communities by way of providing access to novel and compelling therapies for a variety of disease states. The value [...]